Get started
FIBROGEN INC COM USD0.01FIBROGEN INC COM USD0.01FIBROGEN INC COM USD0.01

FIBROGEN INC COM USD0.01

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0IL8 chart


Full chart

0IL8 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪50.24 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.2294 USD
Net income (FY)
‪−284.23 M‬ USD
Revenue (FY)
‪147.75 M‬ USD
Shares float
‪93.69 M‬
Beta (1Y)
3.11

Employees


Employees (FY)
486
Change (1Y)
−106 −17.91%
Revenue / Employee (1Y)
‪304.02 K‬ USD
Net income / Employee (1Y)
‪−584.84 K‬ USD

About FibroGen, Inc


Sector
Health Technology
CEO
Thane Wettig
Headquarters
San Francisco
Website
fibrogen.com
Founded
1993
FIGI
BBG00JVXCX32
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0IL8 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0IL8 is 0.5404 USD — it has increased by 17.48% in the past 24 hours. Watch FIBROGEN INC COM USD0.01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange FIBROGEN INC COM USD0.01 stocks are traded under the ticker 0IL8.
0IL8 stock has risen by 50.36% compared to the previous week, the month change is a 42.21% rise, over the last year FIBROGEN INC COM USD0.01 has showed a −22.80% decrease.
We've gathered analysts' opinions on FIBROGEN INC COM USD0.01 future price: according to them, 0IL8 price has a max estimate of 10.00 USD and a min estimate of 10.00 USD. Watch 0IL8 chart and read a more detailed FIBROGEN INC COM USD0.01 stock forecast: see what analysts think of FIBROGEN INC COM USD0.01 and suggest that you do with its stocks.
0IL8 reached its all-time high on Jul 9, 2018 with the price of 67.9000 USD, and its all-time low was 0.2974 USD and was reached on Oct 28, 2024. View more price dynamics on 0IL8 chart.
See other stocks reaching their highest and lowest prices.
0IL8 stock is 17.74% volatile and has beta coefficient of 3.11. Track FIBROGEN INC COM USD0.01 stock price on the chart and check out the list of the most volatile stocks — is FIBROGEN INC COM USD0.01 there?
Today FIBROGEN INC COM USD0.01 has the market capitalization of ‪50.24 M‬, it has increased by 37.89% over the last week.
Yes, you can track FIBROGEN INC COM USD0.01 financials in yearly and quarterly reports right on TradingView.
FIBROGEN INC COM USD0.01 is going to release the next earnings report on Mar 3, 2025. Keep track of upcoming events with our Earnings Calendar.
0IL8 earnings for the last quarter are −0.17 USD per share, whereas the estimation was −0.31 USD resulting in a 44.50% surprise. The estimated earnings for the next quarter are −0.14 USD per share. See more details about FIBROGEN INC COM USD0.01 earnings.
FIBROGEN INC COM USD0.01 revenue for the last quarter amounts to ‪46.33 M‬ USD, despite the estimated figure of ‪34.84 M‬ USD. In the next quarter, revenue is expected to reach ‪24.91 M‬ USD.
0IL8 net income for the last quarter is ‪−17.08 M‬ USD, while the quarter before that showed ‪−15.54 M‬ USD of net income which accounts for −9.91% change. Track more FIBROGEN INC COM USD0.01 financial stats to get the full picture.
No, 0IL8 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 486.00 employees. See our rating of the largest employees — is FIBROGEN INC COM USD0.01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FIBROGEN INC COM USD0.01 EBITDA is ‪−90.19 M‬ USD, and current EBITDA margin is −175.48%. See more stats in FIBROGEN INC COM USD0.01 financial statements.
Like other stocks, 0IL8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FIBROGEN INC COM USD0.01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FIBROGEN INC COM USD0.01 technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FIBROGEN INC COM USD0.01 stock shows the sell signal. See more of FIBROGEN INC COM USD0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.